Table: begin end state 1 37 cytoplasmic 38 58 transmembrane 59 66 non-cytoplasmic 67 88 transmembrane 89 109 cytoplasmic 110 135 transmembrane 136 157 non-cytoplasmic 158 178 transmembrane 179 187 cytoplasmic 188 210 transmembrane 211 232 non-cytoplasmic 233 254 transmembrane 255 270 cytoplasmic 271 293 transmembrane 294 318 non-cytoplasmic 319 341 transmembrane 342 368 cytoplasmic 369 389 transmembrane 390 394 non-cytoplasmic 395 416 transmembrane 417 427 cytoplasmic 428 447 transmembrane 448 452 non-cytoplasmic 453 472 transmembrane 473 483 cytoplasmic
Input: >CCNA_00435 MVGGTPKVSFWTRRKAIDTITAGHADSHQLKKTLSWPHLVALGVGAIVGTGIYTLTGVGA GLAGPGVILSFLIAGAVCACAALCYAELSTMIPASGSAYTYSYAAMGEPVAWFVGWSLIL EYTLVCAAVAVGWSAHAHGLFKMIGFPDALLAGPHQGGLINMPAVFISMAVAGLLALGTR ESATVNMVLVFVKIIALIVFVVLCLPAFNLAHFTPFMPNGFQAHVPEGAAADAAKVGVMA AASLIFFAFYGFDAVSTAAEETKNPKRDLTIGIVGSMAVCTAIYMIVAAVSIGASRTEVF SKSEAPLVFILESLNHGKIAQLVALAAVIALPTVILAFMYGQSRIFFVMARDGLLPRALS KVNAKTGTPVMMTLLTGVLAAVISGLLSLKDIAELANAGTLWAFIAVGASVILLRLREPN RPRVFSTPLWPIVAPAGILGCLYLFLSLPGKTQLYFLYAHLIGAVVYLAYGMRKSVLAQQ ERA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server